top of page

LuminOre CopperTouch - Research & Studies (The Proof)

The Proof 


LuminOre Copper Touch® anti-microbial copper alloys are the first solid surface registered by the EPA to kill 99.9% of the bacteria that can cause infections when cleaned regularly. Its efficacy is tested and proven, which makes LCT the ideal medical-grade alternative to traditional materials for healthcare, education, hospitality, transportation, your home, and beyond. 


Laboratory tests show LCT is more effective at killing bacteria compared to traditional materials often used as healthcare surfaces, such as stainless steel, plastic, and wood.


EPA-registered, LuminOre Copper Touch® surfaces kill pathogens responsible for causing healthcare-associated infections (HAIs):  


  • Staphylococcus aureus

  • Methicillin-Resistant Staphylococcus aureus (MRSA)

  • Vancomycin-Resistant Enterococcus faecalis (VRE)

  • E. coli O157:H7

  • Pseudomonas aeruginosa

  • Enterobacter aerogenes


Clinical trials have also been conducted in active Intensive Care Units and healthcare facilities. These studies support the results of the EPA GLP tests – copper alloys reduce bacteria continuously and consistently.*





LuminOre Copper Touch® bactericidal copper surfaces represent the first class of solid-surface EPA-registered materials that actively and continuously kill bacteria, 24 hours a day when cleaned regularly.


The LCT team will aid affiliate manufacturers throughout the EPA-registration process and assist with:


  • EPA registration

  • Regulatory compliance

  • Allowable marketing and public health claims associated with EPA registration

  • Labeling and record-keeping


Our EPA Registration and Labeling Manual provide guidance on EPA Registration and licensing requirements, labeling compliance, filing and record-keeping procedures, and marketing and public health claim protocols.


EPA Tests:


LuminOre Copper Touch® alloys have been put through rigorous GLP (Good Laboratory Practices) testing by the EPA to evaluate their effectiveness in killing bacteria1 responsible for many hospital-acquired infections (HAIs). The testing focused on six disease-causing bacteria:


  • E. coli O157:H7, a food-borne pathogen that has been associated with large-scale food recalls


  • Methicillin-Resistant Staphylococcus aureus (MRSA), one of the most virulent strains of antibiotic-resistant bacteria and a common culprit of hospital- and community-acquired infections


  • Staphylococcus aureus, the most common of all bacterial staphylococcus (i.e. staph) infections that can cause life-threatening diseases, including pneumonia and meningitis


  • Vancomycin-Resistant Enterococcus faecalis (VRE), an antibiotic resistant organism responsible for 4% of all HAIs


  • Enterobacter aerogenes, a pathogenic bacterium commonly found in hospitals that causes opportunistic skin infections and impacts other body tissues


  • Pseudomonas aeruginosa, a bacterium that infects the pulmonary tracts, urinary tracts, blood and skin of immunocompromised individuals


Three Test Protocols:


The three GLP test protocols used to support EPA registration of antimicrobial copper alloys with public health claims and associated findings:


  • Efficacy as a Sanitizer:

    • LuminOre Copper Touch® surfaces kill bacteria1 within two hours, proving its efficacy as a sanitizer.


  • Wear Test:

    • LuminOre Copper Touch® efficacy does not wear out or wear down over time and continues to help inhibit the buildup and growth of bacteria1 between routine cleaning and sanitizing steps.


  • Repeated Contamination Test:

    • LuminOre Copper Touch® surfaces work continuously to kill more than 99% bacteria, 24 hours a day, even after repeated contamination.


Significantly Outperforms Stainless Steel.


These EPA tests used stainless steel as the control since it represents the most common material used in hospital and surgical settings.


Public Claims:


Based on EPA Registration, products made with LuminOre Copper Touch® can be marketed with the following public health claims...


Laboratory testing has shown that when cleaned regularly, this surface:


  • Continuously reduces bacterial1 contamination, achieving 99.9% reduction within two hours of exposure, when cleaned regularly.


  • Kills greater than 99.9% of Gram-negative and Gram-positive bacteria1 within two hours of exposure. 


  • Delivers continuous and ongoing antibacterial1 action, remaining effective in killing greater than 99.9% of bacteria1 within two hours.


  • Kills greater than 99.9% of bacteria1 within two hours, and continues to kill more than 99% of bacteria1 even after repeated contamination.


  • Helps inhibit the buildup and growth of bacteria1 within two hours of exposure between routine cleaning and sanitizing steps.

bottom of page